Literature DB >> 11390316

Cerebral revascularization for moyamoya disease in adults.

J Srinivasan1, G W Britz, D W Newell.   

Abstract

Moyamoya disease is a rare entity that results in progressive occlusion of the arteries of the circle of Willis. In adults, this most commonly leads to intraventricular hemorrhage and less frequently to symptoms of ischemia. Without treatment, there is progressive deterioration of neurologic function and re-hemorrhage. Direct superficial temporal artery to middle cerebral artery bypass is considered the treatment of choice, although it's efficacy, particularly for hemorrhagic disease, remains uncertain.

Entities:  

Mesh:

Year:  2001        PMID: 11390316

Source DB:  PubMed          Journal:  Neurosurg Clin N Am        ISSN: 1042-3680            Impact factor:   2.509


  5 in total

1.  Diagnosis and neurosurgical treatment of intracranial vascular occlusive syndromes.

Authors:  Sepideh Amin-Hanjani
Journal:  Curr Treat Options Cardiovasc Med       Date:  2009-06

2.  Non-atherosclerotic vascular disease in the young.

Authors:  Osvaldo Camilo; Larry B Goldstein
Journal:  J Thromb Thrombolysis       Date:  2005-10       Impact factor: 2.300

3.  Surgical Revascularization in North American Adults with Moyamoya Phenomenon: Long-Term Angiographic Follow-up.

Authors:  Eric J Arias; Gavin P Dunn; Chad W Washington; Colin P Derdeyn; Michael R Chicoine; Robert L Grubb; Christopher J Moran; DeWitte T Cross; Ralph G Dacey; Gregory J Zipfel
Journal:  J Stroke Cerebrovasc Dis       Date:  2015-05-09       Impact factor: 2.136

4.  Superficial temporal artery to middle cerebral artery bypass.

Authors:  David W Newell
Journal:  Skull Base       Date:  2005-05

5.  Vascular Remodeling in Moyamoya Angiopathy: From Peripheral Blood Mononuclear Cells to Endothelial Cells.

Authors:  Francesca Tinelli; Sara Nava; Francesco Arioli; Gloria Bedini; Emma Scelzo; Daniela Lisini; Giuseppe Faragò; Andrea Gioppo; Elisa F Ciceri; Francesco Acerbi; Paolo Ferroli; Ignazio G Vetrano; Silvia Esposito; Veronica Saletti; Chiara Pantaleoni; Federica Zibordi; Nardo Nardocci; Maria Luisa Zedde; Alessandro Pezzini; Vincenzo Di Lazzaro; Fioravante Capone; Maria Luisa Dell'Acqua; Peter Vajkoczy; Elisabeth Tournier-Lasserve; Eugenio A Parati; Anna Bersano; Laura Gatti
Journal:  Int J Mol Sci       Date:  2020-08-11       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.